Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss links to metabolic issues in young Indian men.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with early onset androgenetic alopecia have worse lipid profiles.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

PCOS is linked to hormone disorders and issues like infertility and irregular periods.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Kolaviron and quercetin may help treat prostate issues.

Men with hair loss often have abnormal cholesterol levels, so early screening is advised.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Lower adiponectin and higher leptin levels may predict hair loss in alopecia areata.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Ethanol extracts of Aconitum koreanum improved cholesterol levels and protein recovery in rats.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.